Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
12/2003
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/30/2003US6670486 Process for racemization
12/30/2003US6670358 Substituted thioacetamides
12/25/2003US20030236271 Antitumor agents; enzyme inhibitors
12/25/2003US20030236263 Chemical compounds
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236229 For stimulating the immune system, treating proliferative disorders, or microbial infections
12/24/2003WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/24/2003WO2003106446A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
12/24/2003WO2003105781A2 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003074529A3 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
12/24/2003CN1131868C 作为药物的三环△3－哌啶 As a tricyclic drug △ 3- piperidine
12/24/2003CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
12/24/2003CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
12/23/2003US6667330 Cytoprotective; neuroinflammation and neurodegenerative disorders; oxidative stress related conditions
12/23/2003US6667180 Detecting preferential particles in sample; obtain sample, incubate with label, determine amount of bound particles
12/23/2003CA2267800C Tricyclic compounds having activity as ras-fpt inhibitors
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/18/2003WO2003104240A1 Process for producing cyclic thioether and synthetic intermediate thereof
12/18/2003WO2003104239A1 Compound for the treatment of cns disorders
12/18/2003WO2003103661A1 SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003057149A3 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
12/18/2003WO2003050064B1 Mitotic kinesin inhibitors
12/18/2003US20030232994 A microbiocides, or drugs for treating sexual disorders
12/18/2003US20030232984 Contacting a phenyl ester compound with a cyclic compound in the presence of a source of cyanide or fluoride to prepare acylated cyclic 1,3-dicarbonyl compounds
12/18/2003US20030232875 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
12/18/2003US20030232874 Methods and compositions for the treatment of chronic lymphocytic leukemia
12/18/2003US20030232872 Selective serotonin receptor antagonists and therapeutic applications thereof
12/18/2003US20030232846 Caspase inhibitors and uses thereof
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003CA2489255A1 Process for producing cyclic thioether and synthetic intermediate thereof
12/17/2003EP1370562A1 Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1093456B1 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
12/17/2003EP1023296B1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/16/2003US6664249 Bicyclic vasopressin agonists
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/11/2003WO2003102592A2 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures
12/11/2003WO2003101997A1 Process of preparation of olanzapine form i
12/11/2003WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101979A1 Anthelmintic and insecticidal thiophene derivatives
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition
12/11/2003WO2003040288A3 Isotopically coded affinity markers 3
12/11/2003WO2003006468A3 Polymerisable charge transport compounds
12/11/2003US20030229078 Prevent apoptosis; vision defects; central nervous system disorders; antiischemic agents; stroke therapy
12/11/2003US20030229066 Central nervous system diosrders; psychological disorders
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003CA2487666A1 Anthelmintic and insecticidal thiophene derivatives
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP0970086B1 Spiro compounds and the use thereof
12/10/2003EP0853615B1 Piperidine compounds as calcium channel blockers
12/10/2003EP0658211B2 Enzymatic asymmetric reduction process to produce 4 h-thieno(2,3-6)thio pyrane derivatives
12/10/2003CN1130366C Substituted phenylketoenols and preparing method, midbody and their use as pestcides and herbicides
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660727 Photochromic heterocyclically anellated indenochromene compounds
12/04/2003WO2003099823A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099822A2 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003WO2003099805A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003US20030225273 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225129 Polymorphs of clopidogrel hydrogensulfate
12/04/2003US20030225120 Dihydropyridine soft drugs, and related compositions and methods
12/04/2003US20030225113 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
12/04/2003US20030225112 Substituted thieno(3,2-d)pyrimidines, such as N-(2-Methoxy-ethyl)-2-(6-(3,5-dimethylphenyl))thieno(3,2-d)pyrimidinyl-4-yl)-hydrazine; treating proliferative diseases such as cancer
12/04/2003US20030225111 Use of a quinazoline derivative such as 1-(2,6-dichloro-phenyl)-3-(7-(3-morpholinopropoxy)quinazolin-4-yl) urea to produce an antiangiogenic and/or vascular permeability reducing effect
12/04/2003US20030225097 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by np y5 receptor
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030225069 Treating solid tumors, including sarcomas and carcinomas, such as astrocytomas, prostate cancer, breast cancer, small cell lung cancer, and ovarian cancer, leukemias, lymphomas, adult T-cell leukemia/lymphoma, etc.
12/04/2003US20030225061 Protease inhibitors
12/04/2003US20030225055 Having a 1-alkylpyrrolidine structure; 5-alkyl-2-thia-5-azabicyclo(2.2.1) heptan-3-ones or salts thereof useful as synthetic intermediates
12/04/2003CA2487017A1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003CA2487015A1 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/03/2003EP1366050A2 Condensed pyrazindione derivatives as pde inhibitors
12/03/2003EP1366043A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129578C Tetrahydrobenzindole derivs
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003US6656712 Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses
11/2003
11/27/2003WO2003097650A1 Methods for preparation of olanzapine polymorphic form i
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 214